In this research article from Personalized Medicine, explore how disorders such as depression and schizophrenia have been linked to specific neurotransmitter receptor variations.
Evidence from positron emission tomography (PET) scans suggest a link between serotonin levels in the brain and the progression of dementia.
Three-dimensional structural images of the AMPA receptor have been captured for the first time, offering researchers possible new insights into the exact role of this receptor during excitatory neurotransmission.
Research suggests increasing synaptic activity could alleviate SMA symptoms: motor function of mice was improved when treated with a glutamate receptor stimulant.
David Howett reviews a recent paper from Hefendehl et al. that reported that the microenvironment surrounding amyloid plaques disrupts neuronal glutamate homeostasis
Metabolomic evaluation of patients refractory to treatment unearths a number of potentially treatable abnormalities
Researchers have demonstrated that riluzole reduces age-related cognitive decline and may reverse key gene expression changes associated with Alzheimer’s disease.
Differences in the levels of neurotransmitters GABA and glutamate have been observed in patients with obstructive sleep apnea compared with healthy controls.
A link between noradrenergic neurons and depression may provide new avenues for neuropsychiatric treatments for depression.